A primary structural vulnerability highlighted in the regulatory filing involves property and liability insurance protections. As of March 31, 2026, Milky Mist’s physical and manufacturing assets held a gross book value of ₹2,546 crore, against total active insurance coverage of ₹2,441 crore—representing approximately 95.9 percent coverage. The company noted that its annual renewal policies may not fully shield operations against extensive asset damage, product liability litigations, or catastrophic business interruptions, cautioning that future policy terms could face unfavorable rate revisions or capacity constraints.

The prospectus also detailed critical food safety and biological risks inherent to commercial livestock supply chains. Milky Mist cautioned that outbreaks of cattle epidemics, food-borne pathogens, or chemical adulteration within raw milk catchment pools could trigger immediate drops in consumer demand, intense regulatory scrutiny, retailer recalls, and elevated laboratory testing expenses. Furthermore, the company cited risks surrounding allergen labeling and accidental cross-contamination, noting that real or perceived quality lapses in cold-chain distribution could severely damage brand equity across retail and quick-commerce channels.

On corporate governance and leadership, the filing pointed to significant board-level transitions and talent retention challenges. Milky Mist reported zero attrition among its 13 key managerial personnel in fiscal 2026—improving from 7.69 percent in fiscal 2025 and 8.33 percent in fiscal 2024—but noted that high industry competition makes replacing senior leaders resource-intensive. Crucially, the company disclosed that a majority of its current board directors lack prior experience serving on the boards of publicly listed entities, which could introduce compliance friction as the enterprise transitions to public market governance standards.